Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma

Key points – Baseline metabolic tumor volume and the presence of refractory disease predict outcome for patients with relapsed/refractory HL. Metabolic tumor volume improves the predictive power of pretransplantation PET in relapsed/refractory HL.